ABSTRACT
Obstructive sleep apnea syndrome (OSAS) has been shown to increase cardiovascular morbidity and mortality (1,2). The psychomotor sequelae of OSAS including excessive daytime sleepiness, fatigue, and poor quality of sleep resulting from sleep fragmentation are also well recognized (3,4). Therefore, treatment of OSAS is clearly indicated. Tracheotomy was the first treatment of OSAS. It bypasses all forms of obstruction in the upper airway. However, the associated morbidity of tracheotomy prevents its use in a majority of the patients.
